Group One Trading
ORIC icon

Group One Trading’s Oric Pharmaceuticals ORIC Stock Holding History

Group One Trading’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-700
Closed -$3.91K – 8460
2025
Q1 		$3.91K Buy
+700
New +$6.12K ﹤0.01% 6744
2024
Q4 		– Sell
-5,100
Closed -$52.3K – 7771
2024
Q3 		$52.3K Buy
5,100
+100
+2% +$989 ﹤0.01% 4632
2024
Q2 		$35.4K Hold
5,000
– – ﹤0.01% 4784
2024
Q1 		$68.8K Buy
+5,000
New +$59.4K ﹤0.01% 4443
2023
Q4 		– Sell
-6,600
Closed -$39.9K – 7968
2023
Q3 		$39.9K Buy
6,600
+6,200
+1,550% +$50.8K ﹤0.01% 5309
2023
Q2 		$3.1K Buy
+400
New +$2.27K ﹤0.01% 6931
2023
Q1 		– Sell
-11,800
Closed -$69.5K – 7735
2022
Q4 		$69.5K Buy
+11,800
New +$39.8K ﹤0.01% 4755
2022
Q3 		– Sell
-200
Closed -$1K – 8041
2022
Q2 		$1K Hold
200
– – ﹤0.01% 7597
2022
Q1 		$1K Buy
+200
New +$1.8K ﹤0.01% 7855

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Group One Trading's ORIC Position: Q2 2026 in Review

Group One Trading increased its Oric Pharmaceuticals (ORIC) stake by 24,062% in Q2 2026, buying an estimated $218K and bringing the position to 24,162 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #4069.

Group One Trading first reported a position in ORIC in Q2 2022 and has held it in 8 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Group One Trading held 24,162 shares of Oric Pharmaceuticals worth $262K as of Q2 2026.
  • Group One Trading bought 24,062 Oric Pharmaceuticals shares in Q2 2026, an estimated $218K.
  • Oric Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #4069 holding.
  • Group One Trading first reported a position in Oric Pharmaceuticals in Q2 2022 and has held it in 8 quarters since.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.